Bivastat 250mg Injection
By Bivastat
Rx
5ml Injection in a Vial

Composition
Bivalirudin(250mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
July, 2025

liver
When it comes to using Bivastat 250mg Injection in patients with liver disease, it is considered to be safe based on the available information. There is limited data indicating that adjusting the dose of Bivastat 250mg Injection may not be required for these patients. However, it is crucial to consult with your doctor before starting this medication to ensure proper guidance.

kidney
Bivastat 250mg Injection needs caution in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease and dialysis. Consult your doctor before using.

alcohol
When using Bivastat 250mg Injection, avoid alcohol consumption as it is not safe to combine the two.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Bivastat 250mg Injection.

pregnancy
Bivastat 250mg Injection is generally safe during pregnancy based on animal studies with minimal adverse effects. Limited human studies are available; it is advised to consult your doctor.

breastfeeding
Bivastat 250mg Injection may not be safe to use while breastfeeding. Limited data indicates the drug might pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Polypeptides |
Therapeutic Class | CARDIAC |
Action Class | Direct thrombin inhibitor- parenteral |
₹6930
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024